Publications
Preprints and pre-reviewed scientific papers about SARS-COV-2 seroprevalence studies.
Estimation of SARS-CoV-2 infection fatality rate by real-time antibody screening of blood donors
The pandemic due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has tremendous consequences for our societies
Clinical evaluation of an immunochromatographic IgM/IgG antibody assay and chest computed tomography for the diagnosis of COVID-19
We evaluated the clinical performance of an immunochromatographic (IC) IgM/IgG antibody assay for severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) and chest computed tomography (CT) for the diagnosis of Coronavirus disease 2019 (COVID-19)
Cluster of COVID-19 in northern France: A retrospective closed cohort study
The Oise department in France has been heavily affected by COVID-19 in early 2020.
RAPID SEROLOGICAL TESTS HAVE A ROLE IN ASYMPTOMATIC HEALTH WORKERS COVID-19 SCREENING
Health workers are at high risk for SARS-CoV-2 infection and, if asymptomatic, for transmitting the virus on to fragile cancer patients.
COVID-19 Antibody Seroprevalence in Santa Clara County, California
Background Addressing COVID-19 is a pressing health and social concern.
Antibody responses to SARS-CoV-2 in COVID-19 patients: the perspective application of serological tests in clinical practice
We aim to investigate the profile of acute antibody response in COVID-19 patients, and provide proposals for the usage of antibody test in clinical practice.
Overview of SARS-COV-2 studies seroprevalence in context of the worldwide COVID-19 pandemie. You can register a study here: Contribute
serohub@helmholtz-hzi.de
@serohub on Twitter
hzi-braunschweig/serohub on GitHub